TGF-β receptors, in a Smad-independent manner, are required for terminal skeletal muscle differentiation

Experimental Cell Research

Volumn 316, Issue 15, 2010, Pages 2487-2503

  Droguett, Rebeca ^a   Cabello Verrugio, Claudio ^a   Santander, Cristian ^a   Brandan, Enrique ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Myogenesis; Smads; TGF receptors; TGF dependent signaling

Indexed keywords

CREATINE KINASE; MYOGENIN; MYOSIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; ENZYME ACTIVITY; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE;

EID: 77955050318     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.04.031     Document Type: Article

References (65)

1. Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977, 270:725-727.
2. Blau H.M., Pavlath G.K., Hardeman E.C., Chiu C.P., Silberstein L., Webster S.G., Miller S.C., Webster C. Plasticity of the differentiated state. Science 1985, 230:758-766.
3. Massague J., Cheifetz S., Endo T., Nadal-Ginard B. Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. U. S .A. 1986, 83:8206-8210.
4. Riquelme C., Larrain J., Schonherr E., Henriquez J.P., Kresse H., Brandan E. Antisense inhibition of decorin expression in myoblasts decreases cell responsiveness to transforming growth factor beta and accelerates skeletal muscle differentiation. J. Biol. Chem. 2001, 276:3589-3596.
5. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 1998, 67:753-791.
6. Gray P., Bilezikjian L., Vale W. Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan. Mol. Cell Endocrinol. 2002, 188:254-260.
7. Massague J. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 2000, 1:169-178.
8. Piek E., Heldin C., Ten Dijke P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J. 1999, 13:2105-2124.
9. Massague J., Gomis R.R. The logic of TGFbeta signaling. FEBS Lett. 2006, 580:2811-2820.
10. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425:577-584.
11. Feng X.H., Derynck R. Specificity and versatility in TGF-beta signaling through Smads. Annu. Rev. Cell Dev. Biol. 2005, 21:659-693.
12. Yu L., Hebert M.C., Zhang Y.E. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J. 2002, 21:3749-3759.
13. Schiaffino S., Partridge T. Skeletal Muscle Repair and Regeneration. Advances in Muscle Research 2008, 3. Springer.
14. Droguett R., Cabello-Verrugio C., Riquelme C., Brandan E. Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation. Matrix Biol. 2006, 25:332-341.
15. Brandan E., Cabello-Verrugio C., Vial C. Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy. Matrix Biol. 2008, 27:700-708.
16. Larrain J., Carey D.J., Brandan E. Syndecan-1 expression inhibits myoblast differentiation through a basic fibroblast growth factor-dependent mechanism. J. Biol. Chem. 1998, 273:32288-32296.
17. Ugarte G., Brandan E. Transforming growth factor beta (TGF-beta) signaling is regulated by electrical activity in skeletal muscle cells. TGF-beta type I receptor is transcriptionally regulated by myotube excitability. J. Biol. Chem. 2006, 281:18473-18481.
18. Cabello-Verrugio C., Brandan E. A novel modulatory mechanism of transforming growth factor-beta signaling through decorin and LRP-1. J. Biol. Chem. 2007, 282:18842-18850.
19. Laping N.J., Grygielko E., Mathur A., Butter S., Bomberger J., Tweed C., Martin W., Fornwald J., Lehr R., Harling J., Gaster L., Callahan J.F., Olson B.A. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol. Pharmacol. 2002, 62:58-64.
20. Brandan E., Larraín J. Heparan sulfate proteoglycans during terminal skeletal muscle cell differentiation: possible functions and regulation of their expression. Basic Appl. Myol. 1998, 8:107-114.
21. Wrana J.L., Attisano L., Carcamo J., Zentella A., Doody J., Laiho M., Wang X.-F., Massague J. TGFbeta signals through a heteromic protein kinase receptor complex. Cell 1992, 71:1003-1014.
22. Osses N., Brandan E. ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression. Am. J. Physiol. Cell Physiol. 2002, 282:C383-C394.
23. Fuentealba L., Carey D.J., Brandan E. Antisense inhibition of syndecan-3 expression during skeletal muscle differentiation accelerates myogenesis through a basic fibroblast growth factor-dependent mechanism. J. Biol. Chem. 1999, 274:37876-37884.
24. Florini J.R., Ewton D.Z., Magri K.A. Hormones, growth factors, and myogenic differentiation. Annu. Rev. Physiol. 1991, 53:201-216.
25. Massague J., Andres J., Attisano L., Cheifetz S., Lopez-Casillas F., Ohtsuki M., Wrana J.L. TGF-beta receptors. Mol. Reprod. Dev. 1992, 32:99-104.
26. Santander C., Brandan E. Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway. Cell Signal. 2006, 18:1482-1491.
27. Hanafusa H., Ninomiya-Tsuji J., Masuyama N., Nishita M., Fujisawa J., Shibuya H., Matsumoto K., Nishida E. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J. Biol. Chem. 1999, 274:27161-27167.
28. Zhang Z., Cohen D.M. NaCl but not urea activates p38 and jun kinase in mIMCD3 murine inner medullary cells. Am. J. Physiol. 1996, 271:F1234-F1238.
29. Lopez-Casillas F., Wrana J., Massague J. Betaglycan presents ligand to the TGF beta signaling receptor. Cell 1993, 73:1435-1444.
30. Florini J.R., Roberts A.B., Ewton D.Z., Falen S.L., Flanders K.C., Sporn M.B. Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells. J. Biol. Chem. 1986, 261:16509-16513.
31. Allen R.E., Boxhorn L.K. Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta. J. Cell. Physiol. 1987, 133:567-572.
32. Li Y., Foster W., Deasy B.M., Chan Y., Prisk V., Tang Y., Cummins J., Huard J. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am. J. Pathol. 2004, 164:1007-1019.
33. McLennan I.S. Localisation of transforming growth factor beta 1 in developing muscles: implications for connective tissue and fiber type pattern formation. Dev. Dyn. 1993, 197:281-290.
34. Zhou L., Porter J.D., Cheng G., Gong B., Hatala D.A., Merriam A.P., Zhou X., Rafael J.A., Kaminski H.J. Temporal and spatial mRNA expression patterns of TGF-beta1, 2, 3 and TbetaRI, II, III in skeletal muscles of mdx mice. Neuromuscul. Disord. 2006, 16:32-38.
35. Izzi L., Attisano L. Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation. Oncogene 2004, 23:2071-2078.
36. Inoue Y., Imamura T. Regulation of TGF-beta family signaling by E3 ubiquitin ligases. Cancer Sci. 2008, 99:2107-2112.
37. Fukasawa H., Yamamoto T., Togawa A., Ohashi N., Fujigaki Y., Oda T., Uchida C., Kitagawa K., Hattori T., Suzuki S., Kitagawa M., Hishida A. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:8687-8692.
38. Moren A., Imamura T., Miyazono K., Heldin C.H., Moustakas A. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J. Biol. Chem. 2005, 280:22115-22123.
39. Shen H., Huang G., Hadi M., Choy P., Zhang M., Minuk G.Y., Chen Y., Gong Y. Transforming growth factor-beta1 downregulation of Smad1 gene expression in rat hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285:G539-G546.
40. Tsunobuchi H., Ishisaki A., Imamura T. Expressions of inhibitory Smads, Smad6 and Smad7, are differentially regulated by TPA in human lung fibroblast cells. Biochem. Biophys. Res. Commun. 2004, 316:712-719.
41. Koli K.M., Arteaga C.L. Processing of the transforming growth factor beta type I and II receptors. Biosynthesis and ligand-induced regulation. J. Biol. Chem. 1997, 272:6423-6427.
42. Centrella M., Ji C., Casinghino S., McCarthy T.L. Rapid flux in transforming growth factor-beta receptors on bone cells. J. Biol. Chem. 1996, 271:18616-18622.
43. Di Guglielmo G.M., Le Roy C., Goodfellow A.F., Wrana J.L. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat. Cell Biol. 2003, 5:410-421.
44. Ehrlich M., Shmuely A., Henis Y.I. A single internalization signal from the di-leucine family is critical for constitutive endocytosis of the type II TGF-beta receptor. J. Cell Sci. 2001, 114:1777-1786.
45. Hayes S., Chawla A., Corvera S. TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2. J. Cell Biol. 2002, 158:1239-1249.
46. Penheiter S.G., Mitchell H., Garamszegi N., Edens M., Dore J.J., Leof E.B. Internalization-dependent and -independent requirements for transforming growth factor beta receptor signaling via the Smad pathway. Mol. Cell. Biol. 2002, 22:4750-4759.
47. Feng X.H., Derynck R. Ligand-independent activation of transforming growth factor (TGF) beta signaling pathways by heteromeric cytoplasmic domains of TGF-beta receptors. J. Biol. Chem. 1996, 271:13123-13129.
48. Filvaroff E.H., Ebner R., Derynck R. Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-beta receptor. Development 1994, 120:1085-1095.
49. Liu D., Kang J.S., Derynck R. TGF-beta-activated Smad3 represses MEF2-dependent transcription in myogenic differentiation. EMBO J. 2004, 23:1557-1566.
50. Kollias H.D., McDermott J.C. Transforming growth factor-beta and myostatin signaling in skeletal muscle. J. Appl. Physiol. 2008, 104:579-587.
51. Attisano L., Wrana J.L. Signal transduction by the TGF-beta superfamily. Science 2002, 296:1646-1647.
52. Moustakas A., Heldin C.H. Non-Smad TGF-beta signals. J. Cell Sci. 2005, 118:3573-3584.
53. Cuenda A., Cohen P. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J. Biol. Chem. 1999, 274:4341-4346.
54. Cabane C., Englaro W., Yeow K., Ragno M., Derijard B. Regulation of C2C12 myogenic terminal differentiation by MKK3/p38alpha pathway. Am. J. Physiol. Cell Physiol. 2003, 284:C658-C666.
55. Simone C., Forcales S.V., Hill D.A., Imbalzano A.N., Latella L., Puri P.L. p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat. Genet. 2004, 36:738-743.
56. Herz J., Strickland D.K. LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 2001, 108:779-784.
57. Brandan E., Cabello-Verrugio C., Retamal C., Marzolo M.P. The Low Density Lipoprotein Receptor-related Protein Functions as an Endocytic Receptor for Decorin. J. Biol. Chem. 2006, 281:31562-31571.
58. Bessereau J.L., Mendelzon D., LePoupon C., Fiszman M., Changeux J.P., Piette J. Muscle-specific expression of the acetylcholine receptor alpha-subunit gene requires both positive and negative interactions between myogenic factors, Sp1 and GBF factors. EMBO J. 1993, 12:443-449.
59. Biesiada E., Hamamori Y., Kedes L., Sartorelli V. Myogenic basic helix-loop-helix proteins and Sp1 interact as components of a multiprotein transcriptional complex required for activity of the human cardiac alpha-actin promoter. Mol. Cell. Biol. 1999, 19:2577-2584.
60. Chang W., Parra M., Ji C., Liu Y., Eickelberg O., McCarthy T.L., Centrella M. Transcriptional and post-transcriptional regulation of transforming growth factor beta type II receptor expression in osteoblasts. Gene 2002, 299:65-77.
61. Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J., Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G., Hines S., Lewis L., DeRamo C., Delgado O., Dugan-Rocha S., Miner G., Morgan M., Hawes A., Gill R., Celera, Holt R.A., Adams M.D., Amanatides P.G., Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S., Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T., Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D., Lee H.M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L., Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D., Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M., Schein J., Bosdet I., Fjell C., Jones S., Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D., Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M., Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C., Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J., Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H., Chen R., Durbin K.J., Egan A., Ren Y., Song X.Z., Li B., Liu Y., Qin X., Cawley S., Worley K.C., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q., Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P., Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A., Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C., Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J., Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J., Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F., Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A., Hubner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.A., Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J., Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E., Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M., Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C., Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L., Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W., Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y., Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V., Durbin R., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M., Sidow A., Stone E.A., Venter J.C., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S., Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B., Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R., Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J., Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D., Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S., Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S., Mockrin S., Collins F. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 2004, 428:493-521.
62. Piette J., Klarsfeld A., Changeux J.P. Interaction of nuclear factors with the upstream region of the alpha-subunit gene of chicken muscle acetylcholine receptor: variations with muscle differentiation and denervation. EMBO J. 1989, 8:687-694.
63. Bernasconi P., Di Blasi C., Mora M., Morandi L., Galbiati S., Confalonieri P., Cornelio F., Mantegazza R. Transforming growth factor-beta1 and fibrosis in congenital muscular dystrophies. Neuromuscul. Disord. 1999, 9:28-33.
64. Gosselin L.E., McCormick K.M. Targeting the immune system to improve ventilatory function in muscular dystrophy. Med. Sci. Sports Exerc. 2004, 36:44-51.
65. Gosselin L.E., Williams J.E., Deering M., Brazeau D., Koury S., Martinez D.A. Localization and early time course of TGF-beta 1 mRNA expression in dystrophic muscle. Muscle Nerve 2004, 30:645-653.